Submitted by Anonymous (not verified) on 10 September 2025 - 15:20
Human medicines European public assessment report (EPAR): Jakavi, ruxolitinib, Date of authorisation: 23/08/2012, Revision: 37, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Jakavi, ruxolitinib, Date of authorisation: 23/08/2012, Revision: 37, Status: Authorised